Moreover, it has been suggested that synthetic agonists of PPARγ, such as thiazolidinediones (TZDs), like pioglitazone, are anti-inflammatory drugs with ameliorative effects on severe viral pneumonia-like COVID-19 (38). The gene discussed is PPARG; the disease is COVID-19.